Anticholinergics and the risk of pneumonia in the elderly

a systematic literature review

Authors

  • Edinho Pereira Pardin Graduando(a) em Medicina na Universidade do Contestado - UNC.
  • Brenda Zanatta Barbosa Graduando(a) em Medicina na Universidade do Contestado - UNC.
  • Robson Pereira dos Santos Graduando(a) em Medicina na Universidade do Contestado - UNC.
  • Guilherme Sell de Mendonça e Silva Graduando(a) em Medicina na Universidade do Contestado - UNC.
  • Lara Thaís Marcon Graduando(a) em Medicina na Universidade do Contestado - UNC.
  • Lucas Pilatti Kolossovski Graduando(a) em Medicina na Universidade do Contestado - UNC.
  • Betina Villaca Monteiro Graduando(a) em Medicina na Universidade Positivo.
  • Cibele Leite Marsura Graduando(a) em Medicina na Universidade Positivo.
  • Emanuel Racim Munhoz Graduando em Medicina na Universidade de Cuiabá - UNIC
  • Fábio Felber Retroz Médico pela Universidad Nacional Ecológica (Bolívia)/Universidade de Brasília - UNB.
  • Helton Freitas Queiroz Graduando em Medicina na Universidade Brasil.
  • Luiza Racim Munhoz Médica pelo Centro Universitário São Lucas - UNISL.
  • Ailla Gabrielli Costa Silva Graduanda em Enfermagem pela Universidade Federal de Alagoas - UFAL.
  • Ana Vitória Machado Duarte Graduanda em Odontologia no Centro Universitário Santo Agostinho - UNIFSA.
  • Felipe Cardoso Rodrigues Vieira Farmacêutico pela Universidade Federal do Piauí - UFPI.

DOI:

https://doi.org/10.36557/2674-8169.2023v5n4p618-627

Keywords:

Anticholinergics, Pneumonia, Elderly, Systematic review

Abstract

Pneumonia is one of the most common illnesses and one of the main causes of hospitalizations among the elderly. In view of the frequent prescription for the elderly, the possibility of an increased risk of pneumonia due to the use of anticholinergic drugs is an important field of study. This systematic review aims to investigate the association between the use of anticholinergic drugs and the risk of pneumonia in elderly patients. A search was carried out in the PubMed, Web of Science, EBSCO and Google Scholar databases and based on the PRISMA tool and the application of inclusion and exclusion criteria, 6 articles were selected for analysis and discussion. It is inferred that the risk of pneumonia is increased in elderly patients who use anticholinergic drugs, especially more potent anticholinergics and in the treatment initiation phase. Physicians and other health professionals should take this evidence into account in clinical practice with elderly patients.

Downloads

Download data is not yet available.

References

Simonetti AF et al.. Management of community-acquired pneumonia in older adults. Ther Adv Infect Dis. 2014;2(1):1–9.

Torres A et al.. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax. 2013;68(11):1057–1065.

Fick DM et al.. American geriatrics society 2019 updated AGS beers criteria (R) for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–694.

Moher D et al.. Preferred reporting items for systematic reviews and Meta-Analyses: the PRISMA statement (reprinted from annals of internal medicine). Phys Ther. 2009;89(9):873–880.

Paul KJ et al.. Anticholinergic medications and risk of community-acquired pneumonia in elderly adults: a population-based case-control study. J Am Geriatr Soc. 2015;63(3):476–485.

Chatterjee S et al.. Anticholinergic medication use and risk of pneumonia in elderly adults: a nested case-control study. J Am Geriatr Soc. 2016;64(2):394–400.

Lampela P et al.. Anticholinergic exposure and risk of pneumonia in persons with Alzheimer’s disease: a nested case-control study. J Alzheimers Dis. 2017;56(1):119–128.

Kose E et al.. Assessment of aspiration pneumonia using the anticholinergic risk scale. Geriatr Gerontol Int. 2018;18(8):1230–1235.

Lee CY et al.. The prevalence of anticholinergic drugs and correlation with pneumonia in elderly patients: a population-based study in Taiwan. IJERPH. 2020;17(17):6260.

Gradek-Kwinta E et al.. The use of anticholinergic medication is associated with an increased risk of stroke-associated pneumonia. Aging Clin Exp Res. 2022;34(8):1935–1938.

Jackson ML et al.. The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis. 2004;39(11):1642–1650.

Almirall J et al.. New evidence of risk factors for community-acquired pneumonia: a population-based study. Eur Respir J. 2008;31(6):1274–1284.

Lampela P et al.. Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based study. Drugs Aging. 2013;30(5):321–330.

Salahudeen MS, Duffull SB, Nishtala PS. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr. 2015;15(1):31.

Castejon-Hernandez S et al.. Association between anticholinergic burden and oropharyngeal dysphagia among hospitalized older adults. Aging Clin Exp Res. 2021;33(7):1981–1985.

Riquelme R et al.. Community-acquired pneumonia in the elderly - A multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med. 1996;154(5):1450–1455.

Huxley EJ et al.. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med. 1978;64(4):564–568.

Marik PE, Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest. 2003;124(1):328–336.

Published

2023-08-18

How to Cite

Pardin , E. P., Barbosa , B. Z., dos Santos , R. P., Mendonça e Silva , G. S. de, Marcon , L. T., Kolossovski , L. P., Monteiro , B. V., Marsura , C. L., Munhoz , E. R., Retroz, F. F., Queiroz , H. F., Munhoz , L. R., Silva , A. G. C., Duarte, A. V. . M., & Vieira, F. C. R. (2023). Anticholinergics and the risk of pneumonia in the elderly: a systematic literature review. Brazilian Journal of Implantology and Health Sciences, 5(4), 618–627. https://doi.org/10.36557/2674-8169.2023v5n4p618-627

Issue

Section

Systematic Review